BackgroundAlkaptonuria (AKU) is an inborn error of catabolism due to a
deficient activity of homogentisate 1,2-dioxygenase. Patients suffer from a severe
arthropathy, cardiovascular and kidney disease but other organs are affected, too.
We found secondary amyloidosis as a life-threatening complication in AKU, thus
opening new perspectives for its treatment. We proved that methotrexate and
anti-oxidants have an excellent efficacy to inhibit the production of amyloid in
AKU model chondrocytes. Owing to the progressive and intractable condition, it
seems important to detect amyloid deposits at an early phase in AKU and the choice
of specimens for a correct diagnosis is crucial.MethodsTen AKU subjects were examined for amyloidosis; abdominal fat pad
aspirates, labial salivary gland, cartilage and synovia specimens were analysed by
CR, Th-T, IF, TEM.ResultsAmyloid was detected in only one abdominal fat pad specimen.
However, all subjects demonstrated amyloid deposition in salivary glands and in
other organ biopsies, indicating salivary gland as the ideal specimen for early
amyloid detection in AKU.ConclusionsThis is, at the best of our knowledge, the first report providing
correct indications on the diagnosis of amyloidosis in AKU, thus offering the
possibility of treatment of such co-morbidity to AKU patients.Virtual slidesThe virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_185